Search results for " bioprocess"
Article
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
…ingle-use equipment to attain a major role in manufacturing, including dominating the pre-commercial bioprocessing markets, while single-use technology is only just starting to be adopted for commerc…
Article
QbD and PAT in Upstream and Downstream Processing
McKnight, PhD, principal engineer, late stage cell culture, BioProcess Development, Genentech; Anurag Rathore, professor, Indian Institute of Technology (IIT) Delhi; Frederic Girard, CEO, Spinnovation…
Article
Continuous Manufacturing: A Changing Processing Paradigm
Actual use of perfusion for commercial manufacture may even be more widespread, but bioprocessing manufacturers are becoming increasingly reticent to publicly share details about their processes, he s…
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
has published an extensive annual survey of bioprocessing professionals. Since the first survey, which was started in collaboration with the American Society for Microbiology, critical bioprocessing i…
Article
Leveraging Data for Better Biopharmaceutical Process Control
Are more biomanufacturers adopting PAT and advanced control in biopharma?
Menezes:The initial use of PAT in bioprocessing was focused on monitoring specific culture attributes in upstream proce…
Article
Maximum Output Starts with Optimized Upstream Processing
Challener
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
Significant growth in the development and manufa…
Article
Remote Monitoring and Big Data Advance Upstream Automation
Throughout the pharma industry, not just in upstream bioprocessing, there is, adds Dorizon Navarro, life sciences industry consultant at Rockwell Automation, an explosion of the integration of multipl…
Article
Process Development: 2020 Reflections and 2021 Possibilities
Last year in particular reenforced the need to reapproach optimization and flexibility for all bioprocesses, as well as emphasized the importance of life-saving products such as vaccines.
To shed …
Article
Leveraging Computational Models of Glycosylation for Biopharma QA
Biopharmaceutical glycosylation variability is determined by manufacturing bioprocess conditions (1). Large-scale mammalian cell culture is used for the manufacture of all therapeutic glycoproteins (T…
Article
A Q&A with Eric Langer: CMOs Embrace New Technology
Further, if they’re to maintain expertise in bioprocessing, they need to have a fuller ‘toolbox’ of options, innovation, and knowledge at their disposal than other manufacturers who may need to build …